Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting-Reference-Cited by-同舟云学术

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting

Published:2020-04-02 Issue:6 Volume:190 Page:891-900
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Hanekamp Diana¹^ORCID,Snel Alexander N.¹,Kelder Angèle¹,Scholten Willemijn J.¹,Khan Naeem²,Metzner Marlen³,Irno‐Consalvo Maria⁴,Sugita Mayumi⁵,Jong Anja⁶,Oude Alink Sjoerd⁷,Eidhof Harrie⁸,Wilhelm Miriam⁹,Feuring‐Buske Michaela⁹,Slomp Jennichjen⁸,Velden Vincent H. J.⁷^ORCID,Sonneveld Edwin⁶,Guzman Monica⁵,Roboz Gail J.⁵,Buccisano Francesco⁴^ORCID,Vyas Paresh³,Freeman Sylvie²^ORCID,Bachas Costa¹,Ossenkoppele Gert J.¹,Schuurhuis Gerrit J.¹,Cloos Jacqueline¹

Affiliation:

1. Department of Hematology Amsterdam UMC Vrije Universiteit Amsterdam Cancer Center Amsterdam Amsterdam the Netherlands

2. Institute of Immunology and Immunotherapy Department of Clinical Immunology University of Birmingham Birmingham United Kingdom

3. Medical Research Council Molecular Hematology Unit Oxford Centre for Hematology Oxford BRC University of Oxford and Oxford University Hospitals National Health Service Trust Oxford United Kingdom

4. Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy

5. Division of Hematology and Oncology Department of Medicine Weill Cornell Medical College New York NY USA

6. Dutch Childhood Oncology Group Utrecht the Netherlands

7. Department of Immunology Laboratory Medical Immunology Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands

8. Department of Clinical Chemistry Medisch Spectrum Twente/Medlon Enschede the Netherlands

9. Department of Internal Medicine III University Hospital Ulm Ulm Germany

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16594

Reference26 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Molecular Minimal Residual Disease in Acute Myeloid Leukemia

3. Cancer stem cells: mirage or reality?

4. A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia

5. High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-06-12

2. Understanding differential technologies for detection of MRD and how to incorporate into clinical practice;Hematology;2023-12-08

3. Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial;Blood;2023-03-10

4. Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression;Leukemia;2023-02-15

5. Measurable Residual Disease Testing in Acute Leukemia: Technology and Clinical Significance;Leukemia;2022-10-16